Rheumatoid Arthritis

One Year of Abatacept Delays Progression to RA for Up to Four Years in At-Risk Population

Physician’s Briefing

One Year of Abatacept Delays Progression to RA for Up to Four Years in At-Risk Population

23 Jan 2026

2 min read

American College of Rheumatology, Oct. 24-29

Physician’s Briefing

American College of Rheumatology, Oct. 24-29

04 Nov 2025

3 min read

SGLT-2 Inhibitors Tied to Lower Risk for Autoimmune Rheumatic Diseases in Adults With T2D

Physician’s Briefing

SGLT-2 Inhibitors Tied to Lower Risk for Autoimmune Rheumatic Diseases in Adults With T2D

23 Oct 2025

1 min read

Read More

Clinical Briefing Report

clinicalbriefingreport.com